Search

Search Constraints

You searched for: Author/Creator Guidi, Luisa

Search Results

2. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study. Issue 3 (11th February 2020)

3. Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases. (2nd September 2018)

4. Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy. (1st February 2022)

6. Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease. (17th July 2020)

7. Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. Issue 9 (1st November 2019)

8. Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease. Issue 9 (November 2019)

10. FOXP3+ T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents. (24th August 2013)